{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T00:27:00Z","timestamp":1786580820473,"version":"build-2736575974"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T00:00:00Z","timestamp":1785801600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T00:00:00Z","timestamp":1785801600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["81902563"],"award-info":[{"award-number":["81902563"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["62573320"],"award-info":[{"award-number":["62573320"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"name":"the Excellent Youth Science Foundation of Fujian Provincial Natural Science Foundation","award":["No. 2026D016"],"award-info":[{"award-number":["No. 2026D016"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Med"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>The rapid advancement of digital pathology has opened unprecedented opportunities for intelligent diagnosis in renal cell tumor. However, there remains a significant gap in the availability of reliable deep learning models capable of comprehensive kidney cancer detection, classification, grading, and survival prediction.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Method<\/jats:title>\n                    <jats:p>This study retrospectively analyzed 11,135 whole-slide images (WSIs) from 7033 patients with renal tumor, sourced from four medical centers and two public cohorts. Histopathological representations were extracted using the foundation model Prov-GigaPath. A full-stack renal tumor diagnosis and prognosis framework was developed by combining fully supervised learning and weakly supervised multi-instance learning to enable both regional characterization and patient-level inference.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      The deep learning model demonstrated high accuracy in identifying normal tissue (AUC\u2009=\u20090.990), tumor tissue (AUC\u2009=\u20090.982), necrosis tissue (AUC\u2009=\u20090.994), sarcomatoid differentiation (AUC\u2009=\u20090.967), and pseudocapsule tissue (AUC\u2009=\u20090.990) across various pathological types of renal cell tumor. For nine major subtypes of renal cell tumor, classification AUC reached 0.956\u20130.998 across multi-center validation cohorts. WHO\/ISUP nuclear grade prediction for clear cell renal cell carcinoma (ccRCC) and papillary renal cell carcinoma (pRCC) achieved an AUC of 0.867. A whole-slide-derived pan-renal cell tumor pathological risk score independently predicted overall survival and significantly outperformed WHO\/ISUP grading in prognostic stratification (\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&lt;\u20090.001).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>We developed and validated a comprehensive AI framework integrating tissue-region detection, renal tumor subtype classification, nuclear grading, and survival prediction. These findings support its potential as a decision-support tool for renal tumor pathology, while prospective workflow-based studies are warranted to determine its clinical utility and impact on pathologist performance.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12916-026-05110-5","type":"journal-article","created":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T02:47:54Z","timestamp":1785811674000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Artificial intelligence empowers full-stack histopathological diagnosis and prognosis of renal cell tumor: a multi-center study with external validation"],"prefix":"10.1186","volume":"24","author":[{"given":"Ying","family":"Xiong","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Xi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gelei","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoyuan","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianbo","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Run","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yun","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qi","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zilong","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianming","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Le","family":"Qu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yingyong","family":"Hou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2508-9163","authenticated-orcid":false,"given":"Di","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuo","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,8,4]]},"reference":[{"issue":"3","key":"5110_CR1","first-page":"209","volume":"71","author":"H Sung","year":"2021","unstructured":"Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71(3):209\u201349.","journal-title":"CA Cancer J Clin"},{"issue":"5","key":"5110_CR2","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1016\/j.eururo.2022.08.019","volume":"82","author":"L Bukavina","year":"2022","unstructured":"Bukavina L, Bensalah K, Bray F, Carlo M, Challacombe B, Karam JA, et al. Epidemiology of renal cell carcinoma: 2022 update. Eur Urol. 2022;82(5):529\u201342.","journal-title":"Eur Urol"},{"issue":"5","key":"5110_CR3","doi-asserted-by":"publisher","first-page":"458","DOI":"10.1016\/j.eururo.2022.06.016","volume":"82","author":"H Moch","year":"2022","unstructured":"Moch H, Amin MB, Berney DM, Comp\u00e9rat EM, Gill AJ, Hartmann A, et al. The 2022 World Health Organization classification of tumours of the urinary system and male genital organs\u2014Part A: renal, penile, and testicular tumours. Eur Urol. 2022;82(5):458\u201368.","journal-title":"Eur Urol"},{"issue":"1","key":"5110_CR4","doi-asserted-by":"publisher","first-page":"e239","DOI":"10.1016\/j.urolonc.2012.08.011","volume":"32","author":"B Shuch","year":"2014","unstructured":"Shuch B, Hofmann JN, Merino MJ, Nix JW, Vourganti S, Linehan WM, et al. Pathologic validation of renal cell carcinoma histology in the Surveillance, Epidemiology, and End Results program. Urol Oncol. 2014;32(1):e239\u201313.","journal-title":"Urol Oncol"},{"issue":"12","key":"5110_CR5","doi-asserted-by":"publisher","first-page":"1913","DOI":"10.1007\/s00345-018-2447-8","volume":"36","author":"AY Warren","year":"2018","unstructured":"Warren AY, Harrison D. WHO\/ISUP classification, grading and pathological staging of renal cell carcinoma: standards and controversies. World J Urol. 2018;36(12):1913\u201326.","journal-title":"World J Urol"},{"issue":"Suppl 2","key":"5110_CR6","doi-asserted-by":"publisher","first-page":"S24","DOI":"10.1038\/modpathol.2008.183","volume":"22","author":"B Delahunt","year":"2009","unstructured":"Delahunt B. Advances and controversies in grading and staging of renal cell carcinoma. Mod Pathol. 2009;22(Suppl 2):S24\u201336.","journal-title":"Mod Pathol"},{"issue":"6","key":"5110_CR7","doi-asserted-by":"publisher","first-page":"957","DOI":"10.1097\/01.pas.0000249446.28713.53","volume":"31","author":"B Delahunt","year":"2007","unstructured":"Delahunt B, Sika-Paotonu D, Bethwaite PB, McCredie MRE, Martignoni G, Eble JN, et al. Fuhrman grading is not appropriate for chromophobe renal cell carcinoma. Am J Surg Pathol. 2007;31(6):957\u201360.","journal-title":"Am J Surg Pathol"},{"issue":"4","key":"5110_CR8","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1002\/cac2.12012","volume":"40","author":"Y Jiang","year":"2020","unstructured":"Jiang Y, Yang M, Wang S, Li X, Sun Y. Emerging role of deep learning-based artificial intelligence in tumor pathology. Cancer Commun (Lond). 2020;40(4):154\u201366.","journal-title":"Cancer Commun (Lond)"},{"issue":"5","key":"5110_CR9","doi-asserted-by":"publisher","first-page":"775","DOI":"10.1038\/s41591-021-01343-4","volume":"27","author":"J van der Laak","year":"2021","unstructured":"van der Laak J, Litjens G, Ciompi F. Deep learning in histopathology: the path to the clinic. Nat Med. 2021;27(5):775\u201384.","journal-title":"Nat Med"},{"issue":"4","key":"5110_CR10","doi-asserted-by":"publisher","first-page":"686","DOI":"10.1038\/s41416-020-01122-x","volume":"124","author":"A Echle","year":"2021","unstructured":"Echle A, Rindtorff NT, Brinker TJ, Luedde T, Pearson AT, Kather JN. Deep learning in cancer pathology: a new generation of clinical biomarkers. Br J Cancer. 2021;124(4):686\u201396.","journal-title":"Br J Cancer"},{"issue":"8","key":"5110_CR11","doi-asserted-by":"publisher","first-page":"755","DOI":"10.1038\/s43018-020-0099-2","volume":"1","author":"N Coudray","year":"2020","unstructured":"Coudray N, Tsirigos A. Deep learning links histology, molecular signatures and prognosis in cancer. Nat Cancer. 2020;1(8):755\u20137.","journal-title":"Nat Cancer"},{"key":"5110_CR12","doi-asserted-by":"publisher","first-page":"46450","DOI":"10.1038\/srep46450","volume":"7","author":"A Cruz-Roa","year":"2017","unstructured":"Cruz-Roa A, Gilmore H, Basavanhally A, Feldman M, Ganesan S, Shih NNC, et al. Accurate and reproducible invasive breast cancer detection in whole-slide images: a deep learning approach for quantifying tumor extent. Sci Rep. 2017;7:46450.","journal-title":"Sci Rep"},{"issue":"9","key":"5110_CR13","doi-asserted-by":"publisher","first-page":"3950","DOI":"10.1109\/TCYB.2019.2935141","volume":"50","author":"X Wang","year":"2020","unstructured":"Wang X, Chen H, Gan C, Lin H, Dou Q, Tsougenis E, et al. Weakly supervised deep learning for whole slide lung cancer image analysis. IEEE Trans Cybern. 2020;50(9):3950\u201362.","journal-title":"IEEE Trans Cybern"},{"issue":"4","key":"5110_CR14","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1016\/j.euf.2021.07.002","volume":"7","author":"K Kartasalo","year":"2021","unstructured":"Kartasalo K, Bulten W, Delahunt B, Chen PHC, Pinckaers H, Olsson H, et al. Artificial intelligence for diagnosis and Gleason grading of prostate cancer in biopsies\u2014current status and next steps. Eur Urol Focus. 2021;7(4):687\u201391.","journal-title":"Eur Urol Focus"},{"issue":"10","key":"5110_CR15","doi-asserted-by":"publisher","first-page":"1519","DOI":"10.1038\/s41591-019-0583-3","volume":"25","author":"P Courtiol","year":"2019","unstructured":"Courtiol P, Maussion C, Moarii M, Pronier E, Pilcer S, Sefta M, et al. Deep learning-based classification of mesothelioma improves prediction of patient outcome. Nat Med. 2019;25(10):1519\u201325.","journal-title":"Nat Med"},{"issue":"10","key":"5110_CR16","doi-asserted-by":"publisher","first-page":"2868","DOI":"10.1158\/1078-0432.CCR-20-4119","volume":"27","author":"E Marostica","year":"2021","unstructured":"Marostica E, Barber R, Denize T, Kohane IS, Signoretti S, Golden JA, et al. Development of a histopathology informatics pipeline for classification and prediction of clinical outcomes in subtypes of renal cell carcinoma. Clin Cancer Res. 2021;27(10):2868\u201378.","journal-title":"Clin Cancer Res"},{"issue":"3","key":"5110_CR17","doi-asserted-by":"publisher","first-page":"780","DOI":"10.1002\/ijc.33288","volume":"148","author":"S Chen","year":"2021","unstructured":"Chen S, Zhang N, Jiang L, Gao F, Shao J, Wang T, et al. Clinical use of a machine learning histopathological image signature in diagnosis and survival prediction of clear cell renal cell carcinoma. Int J Cancer. 2021;148(3):780\u201390.","journal-title":"Int J Cancer"},{"issue":"1","key":"5110_CR18","first-page":"41","volume":"15","author":"DJ Grignon","year":"1998","unstructured":"Grignon DJ, Eble JN. Papillary and metanephric adenomas of the kidney. Semin Diagn Pathol. 1998;15(1):41\u201353.","journal-title":"Semin Diagn Pathol"},{"issue":"10","key":"5110_CR19","doi-asserted-by":"publisher","first-page":"1490","DOI":"10.1097\/PAS.0b013e318299f0fb","volume":"37","author":"B Delahunt","year":"2013","unstructured":"Delahunt B, Cheville JC, Martignoni G, Humphrey PA, Magi-Galluzzi C, McKenney J, et al. The International Society of Urological Pathology (ISUP) grading system for renal cell carcinoma and other prognostic parameters. Am J Surg Pathol. 2013;37(10):1490\u2013504.","journal-title":"Am J Surg Pathol"},{"issue":"7456","key":"5110_CR20","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1038\/nature12222","volume":"499","author":"Cancer Genome Atlas Research Network","year":"2013","unstructured":"Cancer Genome Atlas Research Network. Comprehensive molecular characterization of clear cell renal cell carcinoma. Nature. 2013;499(7456):43\u20139.","journal-title":"Nature"},{"key":"5110_CR21","doi-asserted-by":"publisher","unstructured":"Akin O, Elnajjar P, Heller M, Jarosz R, Erickson BJ, Kirk S et al. The Cancer Genome Atlas Kidney Renal Clear Cell Carcinoma Collection (TCGA-KIRC) (Version 3) [dataset]. The Cancer Imaging Archive. https:\/\/doi.org\/10.7937\/K9\/TCIA.2016.V6PBVTDR (2016).","DOI":"10.7937\/K9\/TCIA.2016.V6PBVTDR"},{"issue":"2","key":"5110_CR22","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1056\/NEJMoa1505917","volume":"374","author":"Cancer Genome Atlas Research Network","year":"2016","unstructured":"Cancer Genome Atlas Research Network. Comprehensive molecular characterization of papillary renal-cell carcinoma. N Engl J Med. 2016;374(2):135\u201345.","journal-title":"N Engl J Med"},{"key":"5110_CR23","doi-asserted-by":"publisher","unstructured":"Linehan M, Gautam R, Kirk S, Lee Y, Roche C, Bonaccio E et al. The Cancer Genome Atlas Cervical Kidney Renal Papillary Cell Carcinoma Collection (TCGA-KIRP) (Version 4) [dataset]. The Cancer Imaging Archive. https:\/\/doi.org\/10.7937\/K9\/TCIA.2016.ACWOGBEF (2016).","DOI":"10.7937\/K9\/TCIA.2016.ACWOGBEF"},{"issue":"3","key":"5110_CR24","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1016\/j.ccr.2014.07.014","volume":"26","author":"CF Davis","year":"2014","unstructured":"Davis CF, Ricketts CJ, Wang M, Yang L, Cherniack AD, Shen H, et al. The somatic genomic landscape of chromophobe renal cell carcinoma. Cancer Cell. 2014;26(3):319\u201330.","journal-title":"Cancer Cell"},{"key":"5110_CR25","doi-asserted-by":"publisher","unstructured":"Linehan MW, Gautam R, Sadow CA, Levine S. The Cancer Genome Atlas Kidney Chromophobe Collection (TCGA-KICH) (Version 3) [dataset]. The Cancer Imaging Archive. https:\/\/doi.org\/10.7937\/K9\/TCIA.2016.YU3RBCZN (2016).","DOI":"10.7937\/K9\/TCIA.2016.YU3RBCZN"},{"issue":"1","key":"5110_CR26","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1016\/j.ccell.2022.12.001","volume":"41","author":"Y Li","year":"2023","unstructured":"Li Y, Lih TSM, Dhanasekaran SM, Mannan R, Chen L, Cieslik M, et al. Histopathologic and proteogenomic heterogeneity reveals features of clear cell renal cell carcinoma aggressiveness. Cancer Cell. 2023;41(1):139\u2013e16317.","journal-title":"Cancer Cell"},{"key":"5110_CR27","doi-asserted-by":"publisher","unstructured":"National Cancer Institute Clinical Proteomic Tumor Analysis Consortium (CPTAC). The Clinical Proteomic Tumor Analysis Consortium Clear Cell Renal Cell Carcinoma Collection (CPTAC-CCRCC) (Version 14) [dataset]. The Cancer Imaging Archive. https:\/\/doi.org\/10.7937\/K9\/TCIA.2018.OBLAMN27 (2018).","DOI":"10.7937\/K9\/TCIA.2018.OBLAMN27"},{"issue":"8015","key":"5110_CR28","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1038\/s41586-024-07441-w","volume":"630","author":"H Xu","year":"2024","unstructured":"Xu H, Usuyama N, Bagga J, Zhang S, Rao R, Naumann T, et al. A whole-slide foundation model for digital pathology from real-world data. Nature. 2024;630(8015):181\u20138.","journal-title":"Nature"},{"key":"5110_CR29","unstructured":"Ilse M, Tomczak JM, Welling M, 35th International Conference on Machine Learning. Attention-based deep multiple instance learning. In: Dy J, Krause A, editors. Proceedings of the ; 2018 Jul 10\u201315; Stockholm, Sweden. Proc Mach Learn Res. 2018;80:2127-36. https:\/\/proceedings.mlr.press\/v80\/ilse18a.html"},{"issue":"1","key":"5110_CR30","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1038\/s41591-018-0300-7","volume":"25","author":"EJ Topol","year":"2019","unstructured":"Topol EJ. High-performance medicine: the convergence of human and artificial intelligence. Nat Med. 2019;25(1):44\u201356.","journal-title":"Nat Med"},{"issue":"10","key":"5110_CR31","doi-asserted-by":"publisher","first-page":"719","DOI":"10.1038\/s41551-018-0305-z","volume":"2","author":"KH Yu","year":"2018","unstructured":"Yu KH, Beam AL, Kohane IS. Artificial intelligence in healthcare. Nat Biomed Eng. 2018;2(10):719\u201331.","journal-title":"Nat Biomed Eng"},{"issue":"1","key":"5110_CR32","doi-asserted-by":"publisher","first-page":"10509","DOI":"10.1038\/s41598-019-46718-3","volume":"9","author":"S Tabibu","year":"2019","unstructured":"Tabibu S, Vinod PK, Jawahar CV. Pan-renal cell carcinoma classification and survival prediction from histopathology images using deep learning. Sci Rep. 2019;9(1):10509.","journal-title":"Sci Rep"},{"issue":"1","key":"5110_CR33","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1111\/his.13735","volume":"74","author":"B Delahunt","year":"2019","unstructured":"Delahunt B, Eble JN, Egevad L, Samaratunga H. Grading of renal cell carcinoma. Histopathology. 2019;74(1):4\u201317.","journal-title":"Histopathology"},{"issue":"5","key":"5110_CR34","doi-asserted-by":"publisher","first-page":"593","DOI":"10.5858\/2003-127-0593-IAIVUT","volume":"127","author":"M Al-Aynati","year":"2003","unstructured":"Al-Aynati M, Chen V, Salama S, Shuhaibar H, Treleaven D, Vincic L. Interobserver and intraobserver variability using the Fuhrman grading system for renal cell carcinoma. Arch Pathol Lab Med. 2003;127(5):593\u20136.","journal-title":"Arch Pathol Lab Med"},{"issue":"9","key":"5110_CR35","doi-asserted-by":"publisher","first-page":"1091","DOI":"10.1097\/01.pas.0000209833.69972.2b","volume":"30","author":"D Sika-Paotonu","year":"2006","unstructured":"Sika-Paotonu D, Bethwaite PB, McCredie MRE, Jordan TW, Delahunt B. Nucleolar grade but not Fuhrman grade is applicable to papillary renal cell carcinoma. Am J Surg Pathol. 2006;30(9):1091\u20136.","journal-title":"Am J Surg Pathol"},{"issue":"8","key":"5110_CR36","doi-asserted-by":"publisher","first-page":"1134","DOI":"10.1097\/PAS.0b013e318220697f","volume":"35","author":"B Delahunt","year":"2011","unstructured":"Delahunt B, Sika-Paotonu D, Bethwaite PB, Jordan TW, Magi-Galluzzi C, Zhou M, et al. Grading of clear cell renal cell carcinoma should be based on nucleolar prominence. Am J Surg Pathol. 2011;35(8):1134\u20139.","journal-title":"Am J Surg Pathol"},{"issue":"2","key":"5110_CR37","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1016\/j.eururo.2020.11.001","volume":"79","author":"A Lopez-Beltran","year":"2021","unstructured":"Lopez-Beltran A, Montironi R, Cimadamore A, Cheng L. Grading of chromophobe renal cell carcinoma: do we need it? Eur Urol. 2021;79(2):232\u20133.","journal-title":"Eur Urol"},{"issue":"9","key":"5110_CR38","doi-asserted-by":"publisher","first-page":"1224","DOI":"10.1097\/PAS.0000000000000690","volume":"40","author":"LY Khor","year":"2016","unstructured":"Khor LY, Dhakal HP, Jia X, Reynolds JP, McKenney JK, Rini BI, et al. Tumor necrosis adds prognostically significant information to grade in clear cell renal cell carcinoma: a study of 842 consecutive cases from a single institution. Am J Surg Pathol. 2016;40(9):1224\u201331.","journal-title":"Am J Surg Pathol"}],"container-title":["BMC Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12916-026-05110-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12916-026-05110-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12916-026-05110-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,12]],"date-time":"2026-08-12T23:29:00Z","timestamp":1786577340000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12916-026-05110-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,4]]},"references-count":38,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["5110"],"URL":"https:\/\/doi.org\/10.1186\/s12916-026-05110-5","relation":{},"ISSN":["1741-7015"],"issn-type":[{"value":"1741-7015","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,4]]},"assertion":[{"value":"17 March 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 July 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 August 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 August 2026","order":5,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Update","order":6,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The original article has been updated to re-incorporate Equal Contribution for the first six authors.","order":7,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"We followed the declaration of Helsinki and got approved by the ethic committees of Zhongshan Hospital (B2021-608R), Xiamen Clinical Research Center for Cancer Therapy (B2024-134), Zhangye People\u2019s Hospital (B2021-018) and Huadong Hospital (2026K013). Written informed consents were waived by the ethic committees.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"408"}}